Carrick Therapeutics Limited
Carrick Therapeutics Limited
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer | Borderline Resectable Pancreatic Ductal Adenocarcinoma; Locally Advanced Pancreatic Ductal Adenocarcinoma; Resectable Pancreatic Ductal Adenocarcinoma | Recruiting | Phase 1 | 2026-09-21 | NCT07645651 | |
| A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies | Solid Malignancies | Recruiting | Phase 1 / Phase 2 | 2026-09-03 | NCT06600789 |